<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Regadenoson is a coronary <z:chebi fb="1" ids="35620">vasodilator</z:chebi> that causes <z:hpo ids='HP_0001649'>tachycardia</z:hpo> via activation of the sympathetic <z:mp ids='MP_0008912'>nervous</z:mp> system </plain></SENT>
<SENT sid="1" pm="."><plain>We determined whether β(1)-adrenergic blockade can attenuate <z:hpo ids='HP_0001649'>tachycardia</z:hpo> without significantly reducing coronary vasodilation induced by regadenoson </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: Hemodynamics and coronary blood flow (CBF) were measured in conscious dogs </plain></SENT>
<SENT sid="3" pm="."><plain>Baseline CBF and heart rate (HR) were 42 ± 2 mL/min and 87 ± 8 bpm (mean ± <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>), respectively </plain></SENT>
<SENT sid="4" pm="."><plain>Regadenoson (1, 2.5, and 5 μg/kg) increased peak CBF by 129 ± 10, 149 ± 7, and 174 ± 10 mL/min and HR by 48 ± 6, 67 ± 5, and 85 ± 11 bpm, respectively, (<z:hpo ids='HP_0000001'>all</z:hpo> P &lt; .05 vs baseline) </plain></SENT>
<SENT sid="5" pm="."><plain>In the presence of <z:chebi fb="0" ids="6904">metoprolol</z:chebi> (1.5 mg/kg), the peak increases in CBF caused by these three doses of regadenoson were reduced by only 11 ± 7%, 10 ± 4%, and 21 ± 2% (P = NS, &lt;.05, and &lt;.05 vs regadenoson alone), respectively, whereas the regadenoson-induced <z:hpo ids='HP_0001649'>tachycardia</z:hpo> was significantly reduced by 55 ± 8%, 55 ± 4%, and 52 ± 5% (<z:hpo ids='HP_0000001'>all</z:hpo> P &lt; .05) </plain></SENT>
<SENT sid="6" pm="."><plain>In the presence of <z:chebi fb="0" ids="6904">metoprolol</z:chebi>, the duration of the regadenoson-induced increase in CBF was reduced, but the duration of the 2-fold increase in CBF caused by 5 μg/kg regadenoson was still nearly 6��minutes </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: β(1)-Adrenergic blockade with <z:chebi fb="0" ids="6904">metoprolol</z:chebi> attenuated the regadenoson-induced increase in HR more than the increase in CBF </plain></SENT>
</text></document>